Cargando…

A prospective multicenter study on bladder cancer: the COBLAnCE cohort

BACKGROUND: Bladder cancer is a very heterogeneous disease as regards natural history. Environmental exposures, constitutional genetic and/or epigenetic background may affect not only the likelihood of bladder tumor occurrence, but also the histologic type of cancer and its outcome. Currently, only...

Descripción completa

Detalles Bibliográficos
Autores principales:	Benhamou, Simone, Bonastre, Julia, Groussard, Karine, Radvanyi, François, Allory, Yves, Lebret, Thierry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094141/ https://www.ncbi.nlm.nih.gov/pubmed/27809812 http://dx.doi.org/10.1186/s12885-016-2877-x

Ejemplares similares

A Case-Only Genome-Wide Interaction Study of Smoking and Bladder Cancer Risk: Results from the COBLAnCE Cohort
por: Karimi, Maryam, et al.
Publicado: (2023)

Identification of targeted therapy for an aggressive subgroup of muscle-invasive bladder cancers
por: Lebret, Thierry, et al.
Publicado: (2015)

Deregulation of Rab and Rab Effector Genes in Bladder Cancer
por: Ho, Joel R., et al.
Publicado: (2012)

A Novel Epigenetic Phenotype Associated With the Most Aggressive Pathway of Bladder Tumor Progression
por: Vallot, Céline, et al.
Publicado: (2011)

An essential role for decorin in bladder cancer invasiveness
por: El Behi, Mohamed, et al.
Publicado: (2013)

Design of a randomized controlled phase III study of dose dense methotrexate, vinblastine, doxorubicin and cisplatin (dd-MVAC) or gemcitabine and cisplatin (GC) as peri-operative chemotherapy for patients with locally advanced transitional cell cancer of the bladder. The French GETUG/AFU V05 VESPER trial
por: Pfister, Christian, et al.
Publicado: (2020)

A Meta-Analysis of the Relationship between FGFR3 and TP53 Mutations in Bladder Cancer
por: Neuzillet, Yann, et al.
Publicado: (2012)

IGF1R activation and the in vitro antiproliferative efficacy of IGF1R inhibitor are inversely correlated with IGFBP5 expression in bladder cancer
por: Neuzillet, Yann, et al.
Publicado: (2017)

Analysis of the copy number profiles of several tumor samples from the same patient reveals the successive steps in tumorigenesis
por: Letouzé, Eric, et al.
Publicado: (2010)

Analysis of the copy number profiles of several tumor samples from the same patient reveals the successive steps in tumorigenesis
por: Letouzé, Eric, et al.
Publicado: (2010)

Epigenomic mapping identifies an enhancer repertoire that regulates cell identity in bladder cancer through distinct transcription factor networks
por: Neyret-Kahn, Hélène, et al.
Publicado: (2023)

PLEKHS1: A new molecular marker predicting risk of progression of non-muscle-invasive bladder cancer
por: Pignot, Géraldine, et al.
Publicado: (2019)

Artificial intelligence to improve cytology performance in urothelial carcinoma diagnosis: results from validation phase of the French, multicenter, prospective VISIOCYT1 trial
por: Lebret, Thierry, et al.
Publicado: (2023)

Multiple recurrences and risk of disease progression in patients with primary low-grade (TaG1) non–muscle-invasive bladder cancer and with low and intermediate EORTC-risk score
por: Simon, Marie, et al.
Publicado: (2019)

TYRO3 as a molecular target for growth inhibition and apoptosis induction in bladder cancer
por: Dufour, Florent, et al.
Publicado: (2019)

Refining the use of neoadjuvant chemotherapy in locally advanced bladder cancer: from conviction to optimization
por: Culine, Stéphane, et al.
Publicado: (2018)

Inhibition of PI3K pathway increases immune infiltrate in muscle-invasive bladder cancer
por: Borcoman, Edith, et al.
Publicado: (2019)

Visual Basic 2010, VB.NET : los fundamentos del lenguaje : desarrollo con Visual Studio 2010 /
por: Groussard, Thierry
Publicado: (2011)

Avelumab as neoadjuvant therapy in patients with urothelial non-metastatic muscle invasive bladder cancer: a multicenter, randomized, non-comparative, phase II study (Oncodistinct 004 - AURA trial)
por: Martinez Chanza, Nieves, et al.
Publicado: (2021)

Endotracheal Intubation Among the Critically Ill: Protocol for a Multicenter, Observational, Prospective Study
por: Smischney, Nathan, et al.
Publicado: (2018)

Aftercare of Childhood Cancer Survivors in Switzerland: Protocol for a Prospective Multicenter Observational Study
por: Denzler, Sibylle, et al.
Publicado: (2020)

Clinical Application of Radioembolization in Hepatic Malignancies: Protocol for a Prospective Multicenter Observational Study
por: Helmberger, Thomas, et al.
Publicado: (2020)

Remote Assessment of Disease and Relapse in Epilepsy: Protocol for a Multicenter Prospective Cohort Study
por: Bruno, Elisa, et al.
Publicado: (2020)

Characteristics of Interstitial Pneumonia With Autoimmune Features (IPAF): Protocol for a Multicenter Prospective Study
por: Rzepka-Wrona, Patrycja, et al.
Publicado: (2023)

Design and Rationale of the National Tunisian Registry of Atrial Fibrillation: Protocol for a Prospective, Multicenter Trial
por: Ben Halima, Afef, et al.
Publicado: (2018)

Radiation therapy before radical cystectomy combined with immunotherapy in locally advanced bladder cancer – study protocol of a prospective, single arm, multicenter phase II trial (RACE IT)
por: Schmid, Sebastian C., et al.
Publicado: (2020)

Variable- versus constant-frequency sacral neuromodulation in black-zone overactive bladder patients: a study protocol for a multicenter, prospective, randomized, blind, self-controlled trial
por: Meng, Lingfeng, et al.
Publicado: (2021)

A Patient Registry for the Management of Uterine Fibroids in Canada: Protocol for a Multicenter, Prospective, Noninterventional Study
por: Bedaiwy, Mohamed A, et al.
Publicado: (2018)

Extreme Prematurity and Pulmonary Outcomes Program in Saitama: Protocol for a Prospective Multicenter Cohort Study in Japan
por: Namba, Fumihiko, et al.
Publicado: (2021)

AURORA: bariatric surgery registration in women of reproductive age - a multicenter prospective cohort study
por: Jans, Goele, et al.
Publicado: (2016)

Oncological Outcomes of Distal Ureterectomy for High-Risk Urothelial Carcinoma: A Multicenter Study by The French Bladder Cancer Committee
por: Masson-Lecomte, Alexandra, et al.
Publicado: (2022)

ProKaSaRe Study Protocol: A Prospective Multicenter Study of Pulmonary Rehabilitation of Patients With Sarcoidosis
por: Lingner, Heidrun, et al.
Publicado: (2015)

Evaluating the Diagnostic Accuracy of Reflectance Confocal Microscopy to Diagnose Skin Cancer: Protocol for a Prospective, Multicenter Study
por: Herz, Naomi D, et al.
Publicado: (2018)

Treatment of ankle sprain or instability in Korean medicine clinics: A protocol for a prospective multicenter observational study
por: Han, Gajin, et al.
Publicado: (2020)

Design and Rationale of the National Tunisian Registry of Percutaneous Coronary Intervention: Protocol for a Prospective Multicenter Observational Study
por: Hammami, Rania, et al.
Publicado: (2022)

Protocol of the Comparison of Intravesical Therapy and Surgery as Treatment Options (CISTO) study: a pragmatic, prospective multicenter observational cohort study of recurrent high-grade non-muscle invasive bladder cancer
por: Gore, John L., et al.
Publicado: (2023)

Recurrent activating mutations of PPARγ associated with luminal bladder tumors
por: Rochel, Natacha, et al.
Publicado: (2019)

Integrated molecular and pharmacological characterization of patient-derived xenografts from bladder and ureteral cancers identifies new potential therapies
por: Lang, Hervé, et al.
Publicado: (2022)

International pooled study on diet and bladder cancer: the bladder cancer, epidemiology and nutritional determinants (BLEND) study: design and baseline characteristics
por: Goossens, Maria E., et al.
Publicado: (2016)

Single-Incision Multiport/Single Port Laparoscopic Abdominal Surgery (SILAP): A Prospective Multicenter Observational Quality Study
por: Mantke, Rene, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_49qejg4r4b8khs0l11huseud1q